Search Results - "BIALLECK, H"

Mobilized allogeneic peripheral stem/progenitor cell apheresis with Spectra Optia v.5·0, a novel, automatic interface-controlled apheresis system: results from the first feasibility trial by Brauninger, S., Bialleck, H., Thorausch, K., Seifried, E., Bonig, H.

“…Background and Objectives  G‐CSF mobilized peripheral blood stem/progenitor cells are frequently used for allogeneic transplantation. Available manual…”
Get full text

Safety and efficacy of healthy volunteer stem cell mobilization with filgrastim G-CSF and mobilized stem cell apheresis: results of a prospective longitudinal 5-year follow-up study by Mueller, M. M., Bialleck, H., Bomke, B., Brauninger, S., Varga, C., Seidl, C., Seifried, E., Tonn, T., Bonig, H.

“…Background and Objectives  G‐CSF‐mobilized peripheral blood stem cells have long replaced marrow as the major source for allogeneic transplants. Conclusive…”
Get full text

Leucodepletion for hyperleucocytosis - first report on a novel technology featuring electronic interphase management by Schulz, M., Bug, G., Bialleck, H., Serve, H., Seifried, E., Bönig, H.

“…Background and Objectives Therapeutic leucodepletion plays an established role in the initial treatment of patients with acute myeloid leukaemia (AML) and…”
Get full text

Prevalence of hepatitis G virus and its strain variant, the GB agent, in blood donations and their transmission to recipients by Roth, W.K., Waschk, D., Marx, S., Tschauder, S., Zeuzem, S., Bialleck, H., Weber, H., Seifried, E.

“…BACKGROUND: Hepatitis G virus (HGV) and its strain variant, the GB agent (GBV‐C) are independent isolates of a recently identified non‐A through ‐E hepatitis…”
Get full text

Purging of G-CSF-mobilized peripheral autografts in acute leukemia with mafosfamide and amifostine to protect normal progenitor cells by FAUTH, F, MARTIN, H, SONNHOFF, S, BIALLECK, H, WIESNETH, M, MIHANOVIC, B, HOELZER, D

“…In the present study the in vitro growth of CFU-GM from PBPC of patients with AML (n = 11), purged with mafosfamide alone or a combination of mafosfamide and…”
Get full text

Prophylactic and interventional granulocyte transfusions in patients with haematological malignancies and life-threatening infections during neutropenia by Mousset, Sabine, Hermann, Stella, Klein, Stefan A, Bialleck, Heike, Duchscherer, Michaele, Bomke, Barbara, Wassmann, Barbara, Böhme, Angelika, Hoelzer, Dieter, Martin, Hans

“…Patients with haematological malignancies and prolonged periods of neutropenia after chemotherapy are at high risk for severe bacterial and fungal infections…”
Get full text

High prevalence of GBV-C/HGV among relatives of GBV-C/HGV-positive blood donors in blood recipients and in patients with aplastic anemia by Seifried, Carola, Weber, Marijke, Bialleck, Heike, Seifried, Erhard, Schrezenmeier, Hubert, Kurt Roth, W.

“…BACKGROUND: The prevalence of GB virus C (GBV‐C)/HGV is high in individuals with parenteral risk factors. The frequency of GBV‐C/HGV in blood donors is…”
Get full text

Older patients with high‐risk fungal infections can be successfully allografted using non‐myeloablative conditioning in combination with intensified supportive care regimens by Hermann, Stella, Klein, Stefan A., Jacobi, Volkmar, Thalhammer, Axel, Bialleck, Heike, Duchscherer, Michaele, Wassmann, Barbara, Hoelzer, Dieter, Martin, Hans

“…Leukaemic patients with advanced disease and severe fungal infections as well as older patients with substantial co‐morbidity are usually excluded from…”
Get full text

Frequencies of GB virus C/hepatitis G virus genomes and of specific antibodies in German risk and non-risk populations by Nübling, C. Micha, Bialleck, Heike, Fürsch, Andreas J., Scharrer, Inge, Schramm, Wolfgang, Seifried, Erhard, Schmidt, Urban, Staszewski, Schlomo, Löwer, Johannes

“…The prevalence of the new flavivirus GB virus C/hepatitis virus G (GBV‐C/HGV) in different German populations was investigated by detection of viral genomes…”
Get full text

Prevalence of hepatitis G virus genome in blood donors by Seifried, E, Bialleck, H, Weber, H, Kirchmaier, C M, Waschk, E, Marx, S, Tschauder, S, Roth, W K

“…The relevance of the GB virus C/hepatitis G virus (GBV-C/HGV) in blood banking results from its high prevalence in blood donors and the fact that it is present…”
Get more information